NURA Named Exclusive U.S. Distributor for BerbiQ™!

NURA USA Announces Exclusive U.S. Partnership for BerbiQ™

A Breakthrough in High-Bioavailability Berberine 

Irvine, CA — March 27th, 2026 — NURA USA, a leading ingredient solutions provider for the food, beverage, and supplement industries, today announced its exclusive U.S. distribution partnership with Molecules BioLabs for BerbiQ™, a next-generation, highly bioavailable berberine ingredient. 

This partnership reinforces NURA’s commitment to delivering innovative, science-backed ingredients that address key health categories, including metabolic health. 

“We are proud to partner with Molecules BioLabs to bring BerbiQ™ to the U.S. market and address long-standing challenges in berberine efficacy,” said Lily Ruan, President of NURA USA. 

BerbiQ™: Solving Berberine’s Bioavailability Challenge 

BerbiQ™ represents a breakthrough in berberine delivery, utilizing proprietary OMICS Technology and advanced bio-nanotechnology to significantly enhance absorption and efficacy. By complexing berberine with synergistic components such as silymarin and coconut milk proteins, BerbiQ™ enables brands to deliver metabolic health support in optimized formats. 

Backed by published research demonstrating 4.26x higher bioavailability compared to standard berberine (ACS Omega, 2025): 
https://pubs.acs.org/doi/10.1021/acsomega.5c05343 

Key Benefits of BerbiQ™: 

• 4.26x higher bioavailability compared to standard berberine  

• Sustained release for prolonged systemic support  

• Clean label, vegan, and ethically sourced  

• Versatile across capsules, gummies, and functional food applications  

“Choosing the right partner for the U.S. market was critical for us. NURA USA’s commitment to transparency, quality, and deep technical expertise makes them the ideal bridge for our research. We are confident that NURA will provide the high-level support and distribution excellence that an advanced ingredient like BerbiQ™ deserves,” said Dr. Sreeraj Gopi, Founder & Managing Director of Molecules BioLabs.